These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9754279)

  • 1. [Unusual behavior of serum markers in risk evaluation for trisomy 21].
    Guibaud S; Boisson C; Chambon V; Simplot A
    Ann Biol Clin (Paris); 1998; 56(4):439-44. PubMed ID: 9754279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal biochemical diagnostics of inborn developmental defects.
    Malbohan I; Fialová L; Mikulíková L; Hájek Z
    Sb Lek; 1994; 95(4):277-83. PubMed ID: 8867698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
    Cariati E; Brizzi L; Periti E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
    Spencer K
    Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple marker screening.
    Dickerson VM
    West J Med; 1994 Aug; 161(2):161. PubMed ID: 7524245
    [No Abstract]   [Full Text] [Related]  

  • 8. Maternal serum markers levels in consecutive pregnancies: a possible genetic predisposition to abnormal levels.
    Dar H; Merksamer R; Berdichevsky D; David M
    Am J Med Genet; 1996 Jan; 61(2):154-7. PubMed ID: 8669443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 46,XY,i(21q) identified by maternal serum screening.
    Meyers CM; Ghori S; Roberson AE; Blitzer MG; Cohen MM
    Md Med J; 1997 Feb; 46(2):88-9. PubMed ID: 9029908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
    Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR
    Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD; McIntosh SF; Halstead AC
    Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
    Huttly W; Rudnicka A; Wald NJ
    Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA; Ying J; Beazoglou T; Egan JF
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prenatal screening for Down's syndrome].
    Qin Q; Christiansen M; Norgaard-Pedersen B
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):694-7. PubMed ID: 9639772
    [No Abstract]   [Full Text] [Related]  

  • 17. Very low alpha-fetoprotein in Down syndrome maternal serum screening.
    Muller F; Dreux S; Sault C; Galland A; Puissant H; Couplet G; Lemay C; Larcher ME; Renom G;
    Prenat Diagn; 2003 Jul; 23(7):584-7. PubMed ID: 12868089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trisomy 18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result.
    Celentano C; Guanciali-Franchi PE; Liberati M; Prefumo F; Palka G; Rotmensch S
    J Med Screen; 2005; 12(4):203. PubMed ID: 16417699
    [No Abstract]   [Full Text] [Related]  

  • 19. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
    Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
    AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.